angiotensin ii has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y; Lam, MMT; Lee, LTO; Poon, TCW; Sun, L; Wong, AST; Yu, S; Zhang, Q | 1 |
| Ayhan, S; Beyazit, F; Celik, HT; Gungor, T | 1 |
2 other study(ies) available for angiotensin ii and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
Topics: Angiotensin II; Animals; Carcinoma, Ovarian Epithelial; Cell Movement; Endoplasmic Reticulum Stress; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Lipid Metabolism; Lipids; Mice; Neoplasm Metastasis; Peritoneal Neoplasms; Prognosis; Proteomics; Receptor, Angiotensin, Type 1; Spheroids, Cellular; Stearoyl-CoA Desaturase; Xenograft Model Antitumor Assays | 2019 |
Assessment of serum angiotensin-converting enzyme in patients with epithelial ovarian cancer.
Topics: Adult; Aged; Angiotensin II; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Case-Control Studies; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Statistics, Nonparametric | 2015 |